Cargando…

Effect of Sitagliptin on Serum Irisin Levels in Patients with Newly Diagnosed Type 2 Diabetes Mellitus

INTRODUCTION: Irisin is a unique myokine with striking effects on regulating insulin sensitivity and energy metabolism. This study aimed to investigate the changes in serum irisin in patients with newly diagnosed type 2 diabetes mellitus (T2DM) following sitagliptin treatment. METHODS: Thirty-two pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Qiu, Ma, Lirong, Zhang, Yuanying, Zhang, Lin, An, Yu, Liu, Jia, Wang, Guang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994490/ https://www.ncbi.nlm.nih.gov/pubmed/33625721 http://dx.doi.org/10.1007/s13300-021-01023-z

Ejemplares similares

Regulation of Adropin by Sitagliptin monotherapy in participants with newly diagnosed type 2 Diabetes
por: Wang, Qiu, et al.
Publicado: (2022)

Serum Irisin Levels and Clinical Implication in Elderly Patients With Type 2 Diabetes Mellitus
por: Xuan, Xianfa, et al.
Publicado: (2020)

Comparison of the Effects of Continuous Subcutaneous Insulin Infusion and Add-On Therapy with Sitagliptin in Patients with Newly Diagnosed Type 2 Diabetes Mellitus
por: Wan, Heng, et al.
Publicado: (2016)

Efficacy and safety of sitagliptin added to metformin and insulin compared with voglibose in patients with newly diagnosed type 2 diabetes
por: Shi, Chunhong, et al.
Publicado: (2019)

Abstract 35: A study on serum irisin levels in type 2 diabetes mellitus
por: Gumpina, Srinivas Susheel
Publicado: (2022)

Sitagliptin Increases Beta-Cell Function and Decreases Insulin Resistance in Newly Diagnosed Vietnamese Patients with Type 2 Diabetes Mellitus
por: Le, Tuan Dinh, et al.
Publicado: (2020)

Serum irisin levels as a potential marker for diagnosis of gestational diabetes mellitus
por: AL-Ghazali, Majid Jawad, et al.
Publicado: (2020)

PPAR-α Agonist Fenofibrate Decreased Serum Irisin Levels in Type 2 Diabetes Patients with Hypertriglyceridemia
por: Feng, Xiaomeng, et al.
Publicado: (2015)

Assessment of serum and salivary adiponectin levels in newly diagnosed Type II diabetes mellitus patients
por: Kalyani, R Suma, et al.
Publicado: (2020)

Longitudinal changes in serum adropin levels and liver fat content during liraglutide treatment in newly diagnosed patients with type 2 diabetes mellitus and metabolic dysfunction-associated fatty liver disease
por: Zhang, Lin, et al.
Publicado: (2023)

Effects of sitagliptin as initial therapy in newly diagnosed elderly type 2 diabetics: A randomized controlled study
por: Xiao, Xiaoyan, et al.
Publicado: (2016)

Effects of Sitagliptin on Insulin and Glucagon Levels in Type 2 Diabetes Mellitus
por: Kim, Ji Hyun
Publicado: (2015)

Evaluation of serum levels of Irisin as a marker of endothelial dysfunction in patients with type 2 diabetes mellitus
por: Ahmed, Thoraya Mohamed, et al.
Publicado: (2023)

The level of netrin-1 is decreased in newly diagnosed type 2 diabetes mellitus patients
por: Liu, Chenxiao, et al.
Publicado: (2016)

Circulating Levels of Betatrophin and Irisin Are Not Associated with Pancreatic β-Cell Function in Previously Diagnosed Type 2 Diabetes Mellitus Patients
por: Wang, Lingshu, et al.
Publicado: (2016)

Sitagliptin/Metformin Versus Insulin Glargine Combined With Metformin in Obese Subjects With Newly Diagnosed Type 2 Diabetes
por: Ji, Ming, et al.
Publicado: (2016)

Effects of Dapagliflozin and Sitagliptin on Insulin Resistant and Body Fat Distribution in Newly Diagnosed Type 2 Diabetic Patients
por: Sun, Yue, et al.
Publicado: (2020)

Comparison between newly diagnosed hypertension in diabetes and newly diagnosed diabetes in hypertension
por: Liu, Chang-Yuan, et al.
Publicado: (2019)

Efficacy and tolerability of sitagliptin and metformin compared with insulin as an initial therapy for newly diagnosed diabetic patients with severe hyperglycaemia
por: He, Mingqian, et al.
Publicado: (2021)

Serum Irisin Levels, Endothelial Dysfunction, and Inflammation in Pediatric Patients with Type 2 Diabetes Mellitus and Metabolic Syndrome
por: Huerta-Delgado, Anna S., et al.
Publicado: (2020)

Serum Levels of Irisin Predict Cumulative Clinical Outcomes in Heart Failure Patients With Type 2 Diabetes Mellitus
por: Berezin, Alexander A., et al.
Publicado: (2022)

Serum irisin levels are decreased in patients with sepsis, and exogenous irisin suppresses ferroptosis in the liver of septic mice
por: Wei, Shasha, et al.
Publicado: (2020)

Irisin plays an important role in the outcomes of newly diagnosed prediabetes in adults in Guiyang, China
por: He, Xi, et al.
Publicado: (2020)

Serum Levels of Meteorin-Like (Metrnl) Are Increased in Patients with Newly Diagnosed Type 2 Diabetes Mellitus and Are Associated with Insulin Resistance
por: Wang, Kexin, et al.
Publicado: (2019)

High Serum Irisin Level as an Independent Predictor of Diabetes Mellitus: A Longitudinal Population-Based Study
por: Huh, Ji Hye, et al.
Publicado: (2016)

Association of lower serum irisin levels with diabetes mellitus: Irrespective of coronary collateral circulation, and syntax score
por: Akyuz, Aydin, et al.
Publicado: (2021)

Cardiovascular risk of sitagliptin in treating patients with type 2 diabetes mellitus
por: Zeng, De-kang, et al.
Publicado: (2019)

Effect of sitagliptin on expression of skeletal muscle peroxisome proliferator-activated receptor γ coactivator-1α and irisin in a rat model of type 2 diabetes mellitus
por: Liu, Yuntao, et al.
Publicado: (2020)

Serum Soluble Epidermal Growth Factor Receptor Level Increase in Patients Newly Diagnosed with Type 2 Diabetes Mellitus
por: Kim, Ji Min, et al.
Publicado: (2018)

Predictive value of serum irisin for chronic heart failure in patients with type 2 diabetes mellitus
por: Berezin, Alexander A., et al.
Publicado: (2022)

Effect of sodium–glucose co-transporter-2 inhibitors on the levels of serum asprosin in patients with newly diagnosed type 2 diabetes mellitus
por: Jiang, Aijun, et al.
Publicado: (2021)

Sitagliptin as combination therapy in the treatment of type 2 diabetes mellitus
por: Miller, Shannon A, et al.
Publicado: (2009)

Sitagliptin improves albuminuria in patients with type 2 diabetes mellitus
por: Mori, Hiroko, et al.
Publicado: (2013)

Clinical characteristics and beta cell function in Chinese patients with newly diagnosed type 2 diabetes mellitus with different levels of serum triglyceride
por: Zheng, Shuang, et al.
Publicado: (2015)

The Effects of Exenatide and Metformin on Endothelial Function in Newly Diagnosed Type 2 Diabetes Mellitus Patients: A Case–Control Study
por: Hu, Yanjin, et al.
Publicado: (2018)

Insulin Oedema in Newly Diagnosed Type 1 Diabetes Mellitus
por: Baş, Veysel Nijat, et al.
Publicado: (2010)

Circulating LECT2 levels in newly diagnosed type 2 diabetes mellitus and their association with metabolic parameters: An observational study
por: Zhang, Zhen, et al.
Publicado: (2018)

Impaired β Cell Function in Chinese Newly Diagnosed Type 2 Diabetes Mellitus with Hyperlipidemia
por: Ma, Yuhang, et al.
Publicado: (2014)

Serum vitamin D status and circulating irisin levels in older adults with sarcopenia
por: Wang, Yawen, et al.
Publicado: (2022)

Comparison irisin peptide serum level in pregnant women with and without gestational diabetes mellitus: A case–control study
por: Khorasani, Zahra Mazloum, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hkf37kk543lqo7jae0l2k3sj21